Navigation Links
Cellular Dynamics International and Roche Expand Existing Cardiotoxicity Screening Agreement
Date:7/1/2009

MADISON, Wis., July 1 /PRNewswire/ -- Cellular Dynamics International (CDI) and Roche announced today a significant expansion of their existing agreement to test drug development candidates for their potential to cause cardiotoxicity, or damage to heart tissue. The two-year collaboration aims to enhance drug safety testing in order to bring promising therapies to patients faster.

Under this agreement, CDI will supply purified cardiomyocytes, created from induced pluripotent stem cells (iPSCs), to Roche, and the two companies will collaborate to perform various cell characterization, toxicological, and electrophysiological response experiments. The agreement also includes an ongoing cardiomyocyte supply contract post collaboration.

Embarked upon originally in March 2008 as a validation of CDI's human pluripotent stem cell technology, the expanded agreement is a testament to the success of the first phase. This next phase moves the companies toward assessing iPSC-derived cardiomyocytes as a cardiovascular safety pharmacology as well as toxicology tool.

iPSCs are adult tissue cells that have been reprogrammed to a pluripotent, embryonic-like state. Like embryonic stem cells, iPSCs have the ability to differentiate into any cell type in the body. However, because they are created from adult skin cells, not embryos, they enable patient-specific stem cells, an important factor in moving the technology toward personalized medicine.

The goal of the agreement's next phase is to detect drug-induced changes in cardiomyocyte activity across a spectrum of compounds. While it is already standard practice to perform in vitro testing of drug candidates on cardiomyocytes, the cell models currently used have a limited utility to reliably predict conduction-related effects and/o
'/>"/>

SOURCE Cellular Dynamics International (CDI)
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. New Cellular Bioenergetics Workshops Series Inaugurated by Seahorse Bioscience with Two of the Worlds Leading Bioenergetics Researchers
2. MIT, BU engineer cellular circuits that count events
3. Intra-Cellular Therapies Reports Positive Final Results of a Phase II Clinical Trial with ITI-007 in Patients with Sleep Maintenance Insomnia
4. Orange and Medic4all Launched the Worlds First Cellular Tele-Health Service
5. MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting
6. ChanTest to Highlight the Worlds Largest Catalog of Ion Channel-Expressing Cell Lines and Discovery Services at Assays & Cellular Targets Conference, Booth 11
7. Cellumen to Collaborate With the NCTR of the FDA to Apply Cellular Systems Biology (CSB(TM)) to Predictive Toxicology
8. New insights into cellular reprogramming revealed by genomic analysis
9. Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
10. Having Penetrated Israels Domestic Telephony Market, 012 Smile.Communications Prepares for Its Next Goal: Entering Israels Cellular Market
11. Cellular construction methods emulated
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2012)... 2012 Genesis Biopharma, Inc. (OTC/BB: GNBP), ... the posting of the following Letter to Shareholders ... at www.genesis-biopharma.com .  In addition, on May ... Securities and Exchange Commission its Quarterly Report for ... Form 10-Q.  The Form 10-Q includes unaudited interim ...
(Date:5/18/2012)... YORK, May 18, 2012  Intellect Neurosciences, Inc. ... the company,s chairman and CEO, will be presenting ... Conference. (Logo:  http://photos.prnewswire.com/prnh/20111214/NY22484LOGO ) ... is "Prefibrillar Tau Neoepitopes Offer Attractive Targets for ... place on May 21st at the Intercontinental Hotel ...
(Date:5/17/2012)... 2012  In an effort to voice concern on ... the Immune Deficiency Foundation (IDF) offered oral testimony at ... (FDA) public hearing on draft guidance of biosimilars products. ... from the biosimilars pathways in order to protect the ... occurs in people born with an immune system that ...
(Date:5/16/2012)... May 16, 2012  UV Flu Technologies, ... to announce that it has signed a television ... San Bernardino Ca., for the filming of a ... "mini-infomercial." The commercial will run locally, regionally, and ... Comcast and Direct TV. The commercials will be ...
Breaking Biology Technology:Genesis Biopharma Issues Letter To Shareholders 2Genesis Biopharma Issues Letter To Shareholders 3Genesis Biopharma Issues Letter To Shareholders 4Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 2Intellect Neurosciences, Inc. to Present at Neurotech Investing and Partnering Conference 3Immune Deficiency Foundation Urges FDA To Exempt Immunoglobulin From Biosimilars Pathway 2UV Flu Technologies to Commence a National TV Advertising Campaign 2UV Flu Technologies to Commence a National TV Advertising Campaign 3
... year-long "break" in Iraq, Matt Storms is ready to continue ... covered due diligence and corporate clean up, the mechanics of ... Business Technology Transfer (STTR) grants. We thank Matt for his ... Wisconsin entrepreneurs. , , Once you complete your ...
... - The Madison Chapter of the Telecommunications Professionals ... Accelerate Madison , a networking and business support ... organization said the partnership "reflects the increasingly blurred ... technology sector across operations in companies of all ...
... perfect a technology that allows researchers to test new drugs ... And fortunately for one local company, the federal government is ... endeavor. , ,To improve its technology, InvivoSciences, LLC , ... the National Center for Complementary and Alternative Medicine ...
Other Biology Technology:Raising capital through placement agents 2Raising capital through placement agents 3Raising capital through placement agents 4Accelerate Madison to merge with Telecommunications Professionals 2InvivoSciences receives NIH grant for heart technology 2
(Date:5/21/2012)... ANN ARBOR, Mich. Since Darwin, assembling an evolutionary ... of life has been one of the grandest and ... of effort, there,s still no comprehensive tree of life, ... of the 1.8 million or so named species of ... from the U.S. National Science Foundation, a group of ...
(Date:5/21/2012)... build a grand tree of life that brings together everything ... the tiniest bacteria to the tallest tree. , Scientists ... ever since Charles Darwin drew the first sketches in his ... branches of the tree of life, today there is still ... download the entire tree. , "Where can you go ...
(Date:5/21/2012)... but the sight of a needle often causes anxiety ... a team of researchers in Israel, however, can reveal ... in real-time, simply by shining a light through the ... is able to provide high-resolution images of blood coursing ... short-lived fluorescent dyes. , "We have invented a new ...
Breaking Biology News(10 mins):U-M biologist plays key role in effort to create first comprehensive tree of life 2U-M biologist plays key role in effort to create first comprehensive tree of life 3Researchers aim to assemble the tree of life for all 2 million named species 2Researchers aim to assemble the tree of life for all 2 million named species 3New microscope uses rainbow of light to image the flow of individual blood cells 2New microscope uses rainbow of light to image the flow of individual blood cells 3Study finds federal amendments increased gun sales diverted to criminals 88429 1Study finds federal amendments increased gun sales diverted to criminals 88429 2Study finds federal amendments increased gun sales diverted to criminals 88429 3Getting cancer cells to swallow poison 23224 1Getting cancer cells to swallow poison 23224 2Illinois scientists link dietary DHA to male fertility 23222 1Illinois scientists link dietary DHA to male fertility 23222 2
... brown recluse spider, researchers at the University of Pennsylvania School ... pores, called ion channels, in the membrane of cells. The ... Yanping Xu, MD, PhD of the Department of Physiology at ... make this discovery. , The enzyme, sphingomyelinase D (SMase ...
... Scientists at St. Jude Children's Research Hospital have announced ... against one antigenic variant of the avian influenza virus ... virus. Vaccines based on this model might therefore be ... epidemic) until a new vaccine could be developed specifically ...
... a lifetime of daily injections to replace the ... as a host of risks that includes blindness, ... particularly those afflicted with juvenile diabetes, transplants of ... might alleviate these problems. Unfortunately, there are not ...
Other Biology News:Gatekeeping: Penn researchers find new way to open ion channels in cell membranes 2H5N1 vaccine could be basis for life-saving stockpile 2Successful transplantation from pig embryos to mice 2